REBN:NASDAQReborn Coffee, Inc. Analysis
Data as of 2026-04-28 - not real-time
$2.39
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The 20‑day SMA sits above the 50‑day SMA while the 200‑day SMA is just below current price, suggesting a mild short‑term bias. RSI hovers around the midpoint, indicating a neutral momentum, but the MACD line is below its signal, generating a bearish signal. Volume is on a decreasing trend and 30‑day volatility is exceptionally high, compounded by a beta well above market, which amplifies price swings. Market sentiment is in the "Extreme Greed" zone, yet price is testing a clear support level near the lower end of its recent range.
Fundamental outlook: Revenue has surged, but gross and operating margins are weak and profit margin is deeply negative, with operating cash flow and free cash flow both in the red. The balance sheet shows cash far below total debt and a negative book value per share, reflected in a highly negative price‑to‑book ratio. The company recently entered a forbearance agreement and issued warrants, underscoring ongoing financial strain. No dividend is paid, and the outlook for sustainable earnings remains uncertain.
Fundamental outlook: Revenue has surged, but gross and operating margins are weak and profit margin is deeply negative, with operating cash flow and free cash flow both in the red. The balance sheet shows cash far below total debt and a negative book value per share, reflected in a highly negative price‑to‑book ratio. The company recently entered a forbearance agreement and issued warrants, underscoring ongoing financial strain. No dividend is paid, and the outlook for sustainable earnings remains uncertain.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD crossover
- Decreasing trading volume
- Recent forbearance agreement indicating liquidity pressure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth potential
- High volatility and beta
- Ongoing debt restructuring efforts
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Negative book value and earnings
- Potential turnaround if cash flow improves
- Exposure to multiple geographic markets
Key Metrics & Analysis
Financial Health
Revenue Growth80.50%
Profit Margin-112.93%
ROE-248.52%
ROA-34.54%
Debt/Equity143.25
P/B Ratio-4.1
Op. Cash Flow$-6505426
Free Cash Flow$-4051617
Technical Analysis
TrendNeutral
RSI51.2
Support$1.81
Resistance$2.95
MA 20$2.47
MA 50$2.09
MA 200$2.14
MACDBearish
VolumeDecreasing
Fear & Greed Index89.25
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.87
Volatility82.98%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.